ARCT
Arcturus Therapeutics Holdings Inc
13.30$
-7.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -42.2% | +30.0% | +41.0% | -15.6% | -45.9% | +39.9% | -16.6% | -30.0% | -82.0% | -80.2% | +385.1% | – | |
| – | +1.9% | +10.9% | -0.4% | +0.0% | -9.0% | – | – | – | -79.6% | -3.5% | – | – | |
| – | -42.2% | +30.0% | +41.0% | -15.6% | -45.9% | +39.9% | -16.6% | -43.7% | -77.7% | -101.6% | – | – | |
| – | -28.3% | +46.3% | +9.5% | -33.3% | +11.9% | -20.3% | -15.2% | -21.3% | +5.2% | -14.5% | -16.3% | – | |
| – | -6.5% | +18.7% | -17.1% | +7.8% | -6.7% | -8.6% | -8.6% | +0.6% | +34.9% | -32.5% | +16.1% | – | |
| – | -30.9% | +45.4% | +6.5% | -26.2% | +9.8% | -15.0% | -21.8% | -16.1% | +13.4% | -13.5% | -4.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -80.0% | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -70.7% | +40.5% | -140.8% | – | – | – | – | -417,150.0% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.